For the second year, Women’s College Research Institute with The Peter Gilgan Centre for Women’s Cancers at Women’s College Hospital, in partnership with the Canadian Cancer Society, are hosting a free, virtual hereditary cancer seminar series.
This series of virtual lunchtime seminars, running until November 2022, will highlight the most relevant advances in hereditary breast and ovarian cancer research over the last several years. The seminars are tailored to women with a BRCA1 or BRCA2 genetic mutation who are looking for more information and the speakers include leaders in hereditary breast and ovarian cancer research and treatment. Each session offers an opportunity for a live Q&A period to have your questions answered directly from the expert. Sessions run for one hour from 12:00pm – 1:00pm.
Click here to register: virtualcancerseries.eventbrite.ca
|Friday, January 28||Managing cancer risk after age 50||Steven Narod|
|Friday, February 25||Communicating with other family members||Jeanna McCuaig|
|Friday, April 29||Cancer risks and management strategies for those individuals with other gene mutations||Raymond Kim|
|Friday, May 27||Treatment of hereditary breast cancer||Kelly Metcalfe|
|Friday, June 24||Panel discussion/FAQ session with pre-submitted questions||Steven Narod, Marcus Bernardini, Andrea Eisen & Aletta Poll|
|Friday, September 23||Considerations facing young women with a mutation||Joanne Kotsopoulos|
|Friday, October 28||Pancreas, prostate, primary peritoneal||Steven Narod|
|Friday, November 25||Surgical prevention of hereditary breast cancer||Kelly Metcalfe & John Semple|